HANGZHOU, China--(BUSINESS WIRE)--âWe believe our immunoliposomes represent a new generation of targeted chemotherapy drugs which may offer better safety with greater efficacy.â
SUWON, South Korea--(BUSINESS WIRE)--OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today that the first patient has been administered on...
MILPITAS, Calif.--(BUSINESS WIRE)--Applied StemCell, Inc. (ASC) and the California Institute for Regenerative Medicine (CIRM) have partnered as Industry Resource Partners. ASC is offering its...
EDMONTON, Alberta--(BUSINESS WIRE)-- #biomedical--Future Fields, a pioneering biotechnology company that has built the worldâs first synthetic biology system to use fruit flies for recombinant protein production, and Jenthera Therapeutics, a gene editing company focused on delivery of the CRISPR ribonucleoproteins (RNPs), today announced a collaboration focused on the manufacturing of a first-of-its-kind cancer-fighting protein. The Future Fields platform, the EntoEngineâ¢, will be used to mass-produce this n
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the first patient has been dosed in the investigator-led...
BOSTON--(BUSINESS WIRE)--Beaconcure, Inc., the leading clinical data technology and automation company, today announced the closing of its $14 million Series B financing round. The...
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
